Literature DB >> 34458689

Vascular Grafts with Tailored Stiffness and a Ligand Environment via Multiarmed Polymer Sheath for Expeditious Regeneration.

Monica Iglesias-Echevarria1, Richard Johnson1, Michael Rafuse1, Yonghui Ding1, Wei Tan1.   

Abstract

The bypass graft is the mainstream of surgical intervention to treat vascular diseases. Ideal bypass materials, yet to be developed, require mechanical properties, availability, clinically feasible manufacturing logistics, and bioactivities with precise physicochemical cues defined to guide cell activities for arterial regeneration. Such needs instigated our fabrication of vascular grafts, which consist of coaxial, nanostructured fibers exhibiting a polycaprolactone (PCL) core and a photoclickable, 4-arm thiolated polyethylene glycol-norbornene (PEG-NB) sheath. The graft strength and bioactivity were modulated by the PCL concentration and the peptides (RGD, transforming growth factor β-1 or TGF-β1) conjugated to thiol-ene of PEG-NB, respectively. Structural, physical, and mechanical characterizations demonstrated that the fibrous grafts mimicked the key features of the native extracellular matrix, including a crosslinked fiber network for structural stability, viscoelasticity emulating arteries, hydration property, and high porosity for cell infiltration. Meanwhile, these grafts displayed strength and toughness exceeding or meeting surgical criteria. Furthermore, the grafts with higher PCL concentration (3 vs 1.8%) showed thicker fibers, lower porosity and pore size, and increased elastic and storage moduli. Graft bioactivity was determined by the mesenchymal stem cell (MSC) behaviors on the grafts and arterial regeneration in vivo using interposition grafting. Results showed that the cell adhesion and proliferation increased with the RGD density (25 vs 5 mM). After 1 week implantation, all peptide-functionalized PCL/PEG-NB grafts with or without MSC preseeding, as opposed to PCL grafts, showed expeditious endothelial lining, abundant vascular cell infiltration, and matrix production. Compared to RGD grafts, RGD/TGF-β1 grafts enhanced MSC differentiation into smooth muscle cells in vitro and developed thicker smooth muscle cell layers in vivo. Overall, the versatile porous vascular grafts offer superior properties and tunability for future translation.

Entities:  

Keywords:  coaxial electrospun fiber; multi-armed polymer; polyethylene glycol-norbornene; regeneration; stiffness; vascular graft

Mesh:

Substances:

Year:  2020        PMID: 34458689      PMCID: PMC8386521          DOI: 10.1021/acsabm.0c01114

Source DB:  PubMed          Journal:  ACS Appl Bio Mater        ISSN: 2576-6422


  36 in total

1.  Biaxial mechanical properties of intact and layer-dissected human carotid arteries at physiological and supraphysiological loadings.

Authors:  Gerhard Sommer; Peter Regitnig; Lukas Költringer; Gerhard A Holzapfel
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-12-24       Impact factor: 4.733

2.  Role of Bone Marrow Mononuclear Cell Seeding for Nanofiber Vascular Grafts.

Authors:  Takuma Fukunishi; Cameron A Best; Chin Siang Ong; Tyler Groehl; James Reinhardt; Tai Yi; Hideki Miyachi; Huaitao Zhang; Toshiharu Shinoka; Christopher K Breuer; Jed Johnson; Narutoshi Hibino
Journal:  Tissue Eng Part A       Date:  2017-06-13       Impact factor: 3.845

3.  Biodegradable and elastomeric vascular grafts enable vascular remodeling.

Authors:  Meifeng Zhu; Yifan Wu; Wen Li; Xianhao Dong; Hong Chang; Kai Wang; Pingli Wu; Jun Zhang; Guanwei Fan; Lianyong Wang; Jianfeng Liu; Hongjun Wang; Deling Kong
Journal:  Biomaterials       Date:  2018-09-01       Impact factor: 12.479

4.  End-point immobilization of heparin on plasma-treated surface of electrospun polycarbonate-urethane vascular graft.

Authors:  Xuefeng Qiu; Benjamin Li-Ping Lee; Xinghai Ning; Niren Murthy; Nianguo Dong; Song Li
Journal:  Acta Biomater       Date:  2017-01-06       Impact factor: 8.947

5.  Regulation of macrophage polarization and promotion of endothelialization by NO generating and PEG-YIGSR modified vascular graft.

Authors:  Di Tang; Siyuan Chen; Ding Hou; Jingchen Gao; Li Jiang; Jie Shi; Qinge Liang; Deling Kong; Shufang Wang
Journal:  Mater Sci Eng C Mater Biol Appl       Date:  2017-11-11       Impact factor: 7.328

6.  Engineering the mechanical and biological properties of nanofibrous vascular grafts for in situ vascular tissue engineering.

Authors:  Jeffrey J D Henry; Jian Yu; Aijun Wang; Randall Lee; Jun Fang; Song Li
Journal:  Biofabrication       Date:  2017-08-17       Impact factor: 9.954

Review 7.  Vascular Tissue Engineering: Progress, Challenges, and Clinical Promise.

Authors:  H-H Greco Song; Rowza T Rumma; C Keith Ozaki; Elazer R Edelman; Christopher S Chen
Journal:  Cell Stem Cell       Date:  2018-03-01       Impact factor: 24.633

8.  Highly Compliant Vascular Grafts with Gelatin-Sheathed Coaxially Structured Nanofibers.

Authors:  Naveen Nagiah; Richard Johnson; Roy Anderson; Winston Elliott; Wei Tan
Journal:  Langmuir       Date:  2015-11-19       Impact factor: 3.882

Review 9.  Concise review: tissue-engineered vascular grafts for cardiac surgery: past, present, and future.

Authors:  Hirotsugu Kurobe; Mark W Maxfield; Christopher K Breuer; Toshiharu Shinoka
Journal:  Stem Cells Transl Med       Date:  2012-06-28       Impact factor: 6.940

10.  The Tissue-Engineered Vascular Graft-Past, Present, and Future.

Authors:  Samand Pashneh-Tala; Sheila MacNeil; Frederik Claeyssens
Journal:  Tissue Eng Part B Rev       Date:  2015-10-08       Impact factor: 6.389

View more
  2 in total

1.  Matrix stiffness exacerbates the proinflammatory responses of vascular smooth muscle cell through the DDR1-DNMT1 mechanotransduction axis.

Authors:  Jin Wang; Si-An Xie; Ning Li; Tao Zhang; Weijuan Yao; Hucheng Zhao; Wei Pang; Lili Han; Jiayu Liu; Jing Zhou
Journal:  Bioact Mater       Date:  2022-01-14

Review 2.  Applying Principles of Regenerative Medicine to Vascular Stent Development.

Authors:  Prakash Parthiban Selvakumar; Michael Scott Rafuse; Richard Johnson; Wei Tan
Journal:  Front Bioeng Biotechnol       Date:  2022-03-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.